Sector: Pharmaceuticals

Latest content

Canada

Featured in Pharmaceutical Trademarks 2010 - A Global Guide

In Canada, prescription drugs can be sold only once they have successfully completed the drug review process and a notice of compliance (NOC) and drug identification number (DIN) have been issued. The Therapeutic Products Directorate of Health Canada will assess the safety, efficacy and quality of a drug; if it concludes that the benefits outweigh the risks, the drug will be issued an NOC and DIN.

22 September 2010

South Africa

Featured in Pharmaceutical Trademarks 2010 - A Global Guide

South African trademark law is governed by the Trademarks Act (194/1993). Section 10 sets out the criteria for registering trademarks, including both absolute and relative grounds for refusal. In addition, applicants for pharmaceutical trademarks should be aware of the regulatory environment for medicines in South Africa.

22 September 2010

United Kingdom

Featured in Pharmaceutical Trademarks 2010 - A Global Guide

The principal legislation governing trademarks in the United Kingdom is the Trademarks Act 1994. Regulation and enforcement of the rules governing the pharmaceutical industry are carried out by the Medicines and Healthcare Products Regulatory Agency. In instances where EU-wide approval is required, the relevant regulatory authority is the European Medicines Agency.

22 September 2010

Brazil

Featured in Pharmaceutical Trademarks 2010 - A Global Guide

The Brazilian Patent and Trademark Office is responsible for granting trademark registrations in Brazil, in accordance with the Industrial Property Law (Law 9.279/96). The National Agency of Health Control controls the production and marketing of products and services in the health sector, including pharmaceutical drugs.

22 September 2010

India

Featured in Pharmaceutical Trademarks 2010 - A Global Guide

The drug controller general of India approves new chemical products introduced into the country. The manufacture, distribution, sale or stocking of any drug requires a licence issued by the authorities established under the Drugs and Cosmetics Act 1940. Under these provisions, a penalty can be imposed for the manufacture, sale, stocking, exhibition or distribution of drugs without a valid licence.

22 September 2010

Finland

Featured in Pharmaceutical Trademarks 2009 - A Global Guide

The primary bodies dealing with pharmaceutical trademarks are those involved in granting and administering registrations for trademarks. Marks concerning the territory of Finland can be registered nationally, in the form of an international registration or as a Community trademark.

22 February 2009

France

Featured in Pharmaceutical Trademarks 2009 - A Global Guide

Pharmaceutical products and, consequently, pharmaceutical trademarks are highly regulated in France. Both national and EU laws and regulations govern various aspects of pharmaceuticals’ development and commercialization, including the intellectual property derived from them.

22 February 2009

United States

Featured in Pharmaceutical Trademarks 2009 - A Global Guide

The chemical name for the molecular structure of a drug, the generic name and, eventually, a brand name are the three components of the drug naming process.

22 February 2009

United Kingdom

Featured in Pharmaceutical Trademarks 2009 - A Global Guide

In the United Kingdom, pharmaceutical trademarks are governed by both trademark law and industry regulation. The relevant trademark legislation is the Trademarks Act 1994, while the relevant regulatory authority is the Medicines and Healthcare Products Regulatory Agency.

22 February 2009

Pakistan

Featured in Pharmaceutical Trademarks 2009 - A Global Guide

The Drugs Act 1976 and the rules framed thereunder provide for the registration of pharmaceutical products and the grant of manufacturing, import, packaging and sales licences in respect of such products.

22 February 2009

Unlock unlimited access to all WTR content